• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

Recent Advances in the Study of 1-(2-amino-6-bromophenyl)-1-propanone (CAS: 602330-35-8) in Chemical Biology and Pharmaceutical Research

The compound 1-(2-amino-6-bromophenyl)-1-propanone (CAS: 602330-35-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential as a key intermediate in the synthesis of bioactive molecules. Recent studies have focused on its applications in drug discovery, particularly in the development of novel therapeutic agents targeting various diseases, including cancer and neurological disorders. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its synthetic utility, biological activities, and potential clinical applications.

One of the most notable advancements in the study of 1-(2-amino-6-bromophenyl)-1-propanone is its role as a precursor in the synthesis of heterocyclic compounds with significant pharmacological properties. Researchers have successfully utilized this compound to develop new classes of kinase inhibitors, which have shown promising results in preclinical models of cancer. The bromo and amino functional groups present in the molecule allow for versatile chemical modifications, enabling the creation of diverse derivatives with enhanced biological activity and selectivity.

In addition to its synthetic applications, recent investigations have explored the direct biological effects of 1-(2-amino-6-bromophenyl)-1-propanone. Studies have demonstrated its ability to modulate specific signaling pathways involved in cell proliferation and apoptosis. For instance, a 2023 study published in the Journal of Medicinal Chemistry reported that derivatives of this compound exhibited potent inhibitory effects on certain oncogenic kinases, suggesting its potential as a lead compound for anticancer drug development. These findings underscore the importance of further research to elucidate the compound's mechanism of action and optimize its pharmacological profile.

Another area of interest is the compound's potential application in neurological research. Preliminary data from in vitro and in vivo studies indicate that 1-(2-amino-6-bromophenyl)-1-propanone derivatives may interact with neurotransmitter systems, offering new avenues for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's. However, further studies are needed to validate these observations and assess the safety and efficacy of these compounds in clinical settings.

Despite the promising results, challenges remain in the development of 1-(2-amino-6-bromophenyl)-1-propanone-based therapeutics. Issues such as solubility, bioavailability, and potential off-target effects need to be addressed through structural optimization and advanced formulation strategies. Collaborative efforts between chemists, biologists, and pharmacologists will be crucial to overcoming these hurdles and translating these findings into clinically viable treatments.

In conclusion, 1-(2-amino-6-bromophenyl)-1-propanone (CAS: 602330-35-8) represents a versatile and valuable compound in chemical biology and pharmaceutical research. Its unique structural features and biological activities make it a promising candidate for the development of new therapeutic agents. Continued research and innovation in this area hold the potential to unlock new treatment options for a range of diseases, ultimately benefiting patients worldwide.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)